Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab. | Rheumatology (Oxford);47(4): 552-3, 2008 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Brasil - Virtual Health Library

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab.

McGonagle, D; Tan, A L; Madden, J; Rawstron, A C; Rehman, A; Emery, P; Thomas, S.

Rheumatology (Oxford) ; 47(4): 552-3, 2008 Apr.

Article in En | MEDLINE | ID: mdl-18281368

Subject(s)

Antibodies, Monoclonal/therapeutic use; Antirheumatic Agents/therapeutic use; Pulmonary Fibrosis/drug therapy; Scleroderma, Systemic/complications; Antibodies, Monoclonal, Murine-Derived; Female; Humans; Middle Aged; Rituximab; Tomography, X-Ray Computed

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Fibrosis / Scleroderma, Systemic / Antirheumatic Agents / Antibodies, Monoclonal Type of study: Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Rheumatology (Oxford) Year: 2008 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Fibrosis / Scleroderma, Systemic / Antirheumatic Agents / Antibodies, Monoclonal Type of study: Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Rheumatology (Oxford) Year: 2008 Document type: Article